Journal
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
Volume 44, Issue 5, Pages 653-659Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.ejps.2011.10.012
Keywords
Oral vaccine delivery; Immunological adjuvant; Carbon nanoparticles
Categories
Funding
- National Basic Research Program of China (973 Program) [2009CB930300]
Ask authors/readers for more resources
The purpose of this study is to develop a novel kind of adjuvant for oral vaccine delivery. In order to effectively prevent the degradation of antigens in the gastrointestinal tract and optimize the uptake for M cells, a novel kind of hydrophobic carbon nanoparticle (C1) with the size of 470 nm was synthesized by taking silica as a template and sucrose as a carbon source. Notably, there were large mesopores and macropores mainly of 40-60 nm, which made it to be excellent candidate as an antigen carrier. Cl was characterized using SEM, TEM and nitrogen adsorption. Following oral immunization with BSA loaded in Cl, the IgG titer reached to a level almost equal to that of parenteral administration of antigen emulsified in Freund's complete adjuvant (ECA). Mucosal IgA was also detected in intestinal, salivary and vaginal secretions, suggesting an effective stimulation of mucosal immune response. Besides, both T-helper 1 and T-helper 2 (Th1 or Th2) mediated responses were induced. We believe that the research will help in the design of novel vaccine adjuvant for improvement their potential on modulation of immune response. (C) 2011 Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available